Use of positron emission tomography to study the dynamics of psychostimulant-induced dopamine release

Pharmacology Biochemistry and Behavior

Volumn 57, Issue 3, 1997, Pages 477-486

  MacH, Robert H ^a   Nader, Michael A ^a   Ehrenkaufer, Richard L E ^a   Line, Scott W ^a   Smith, Cynthia R ^a   Gage, H Donald ^a   Morton, Thomas E ^a  

^a Dept Physiol Pharmacol Dept C ^*  (United States)

Author keywords

Dopamine D2 receptors; Positron emission tomography; Psychostimulants; Rhesus monkey

Indexed keywords

AMPHETAMINE; CLEBOPRIDE; COCAINE; DEXAMPHETAMINE; DOPAMINE 2 RECEPTOR; METHAMPHETAMINE; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHESUS MONKEY; TECHNIQUE;

ANIMALS; BRAIN; DOPAMINE; DOPAMINE ANTAGONISTS; MACACA MULATTA; NARCOTICS; RACLOPRIDE; RADIOLIGAND ASSAY; SALICYLAMIDES; TOMOGRAPHY, EMISSION-COMPUTED;

ANIMALIA; MACACA MULATTA;

EID: 0030751188     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00449-2     Document Type: Article

References (54)

1. Balster R. L., Schuster C. R. A comparison of d-amphetamine, l-amphetamine, and methamphetamine self-administration in rhesus monkeys. Pharmacol. Biochem. Behav. 1:1973;67-71.
2. 2 antagonists. Behav. Pharmacol. 1:1990;355-363.
3. 3 dopamine receptors. Science. 260:1993;1814-1816.
4. Camp D. M., Browman K. E., Robinson T. E. The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fisher 344 rats. Brain Res. 668:1994;180-193.
5. Denau G., Yanagita T., Seevers M. H. Self-administration of psychoactive substances by the monkey. Psychopharmacologia (Berl.). 16:1969;30-48.
6. Dewey S. L., Smith G. S., Logan J., Alexoff D., Ding Y.-S., King P., Pappas N., Brodie J. D., Ashby C. R. Jr. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J. Neurosci. 15:1995;821-829.
7. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse. 13:1993;350-356.
8. 11C-raclopride and positron emission tomography. J. Neurosci. 12:1992;3773-3780.
9. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:1988;5274-5278.
10. 18F]N-methylspiperidol in baboon using PET. Nucl. Med. Biol. 13:1986;281-284.
11. Griffiths R. R., Bigelow G. E., Henningfield J. E. Similarities in animal and human drug-taking behavior. Mello N. K. Advances in substance abuse, vol. 1. 1980;1-90 JAI Press, Greenwich, CT.
12. 3H]raclopride to rat and human brain membranes. J. Neurochem. 55:1990;2048-2057.
13. Harvey J. A. Behavioral pharmacology of central nervous system stimulants. Neuropharmacology. 26:1987;887-892.
14. Henry D. J., Greene M. A., White F. J. Electrophysiological studies of cocaine in the mesoaccumbens dopamine system. Repeated administration J. Pharmacol. Exp. Ther. 251:1989;831-839.
15. Imperato A., Mele A., Scrocco M. G., Puglisi-Allegra S. Chronic cocaine alters limbic extracellular dopamine. Neurochemical basis for addiction. Eur. J. Pharmacol. 212:1992;299-300.
16. 2 receptor in nonhuman primates. Synapse. 10:1992;177-184.
17. Johanson C. E., Balster R. L., Bonese K. Self-administration of psychomotor stimulant drugs. The effects of unlimited access Pharmacol. Biochem. Behav. 4:1976;45-51.
18. Johanson C. E., Fischman M. W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41:1989;3-52.
19. Johanson C. E., Schuster C. R. Animal models of drug self-administration. Mello N. K. Advances in substance abuse, vol. 2. 1981;219-297 JAI Press, Inc, Greenwich, CT.
20. Koob G. F. Drugs of abuse. Anatomy, pharmacology and function of reward pathways Trends Pharmacol. Sci. 13:1992;177-184.
21. Kuczenski R., Segal D. S., Cho A. K., Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and meth-amphetamine. J. Neurosci. 15:1995;1308-1317.
22. Kuhar M. J., Ritz M. C., Boja J. W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14:1991;299-302.
23. 2 receptors J. Labelled Compd. & Radiopharm. 37:1995;21-23.
24. 2 receptor-based imaging agents Nucl. Med. Biol. 20:1993;777-794.
25. 2 receptor with positron emission tomography. J. Med. Chem. 36:1993;3707-3720.
26. 18F]fluorobenzyliodide. J. Labelled Compd. & Radiopharm. 35:1994;157-159.
27. 2 receptors. In vitro binding studies and positron emission tomography Synapse. 24:1996;322-333.
28. 3H]Cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther. 251:1989;131-141.
29. 1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat. Pharmacol. Biochem. Behav. 45:1993;239-242.
30. Martin-Iverson M. An animal model of stimulant psychoses. Boulton A., Baker G., Martin-Iverson M. Neuromethods. Animal models in psychiatry, vol. 18:1991;103-149 Humana Press, Inc, Clifton, NJ.
31. Melega W. P., Williams A. E., Schmitz D. A., DiStefano E. W., Cho A. K. Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal. J. Pharmacol. Exp. Ther. 274:1995;90-96.
32. Moghaddam B., Berridge C. W., Goldman-Rakic P. S., Bunney B. S., Roth R. H. In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate. Synapse. 13:1993;215-222.
33. Muir J. K., Ellis E. F. Acute cocaine administration alters posttraumatic blood pressure and cerebral blood flow in rats. Am. J. Physiol. 268:1995;H68-H73.
34. 3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure. Psychopharmacology. 125:1996;13-22.
35. Parran T. V., Jasinski D. R. Intravenous methylphenidate abuse. Prototype for prescription drug abuse. Arch. Intern. Med. 151:1991;781-783.
36. Pearlson G. D., Jeffery P. J., Harris G. J., Ross C. A., Fischman M. W., Camargo E. E. Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects. Am. J. Psychiatry. 150:1993;495-497.
37. Pifl C., Drobny H., Reither H., Hornykiewicz O., Singer E. A. Mechanism of the dopamine-releasing actions of amphetamine and cocaine. Plasmalemmal dopamine transporter versus vesicular monoamine transporter Mol. Pharmacol. 47:1995;368-373.
38. Ritz M. C., Lamb R. J., Goldberg S. R., Kuhar M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
39. Saunders R. C., Kolachana B. S., Weinberger D. R. Local pharmacological manipulation of extracellular dopamine levels in the dorsolateral prefrontal cortex and caudate nucleus in the rhesus monkey. An in vivo microdialysis study Exp. Brain Res. 98:1994;44-52.
40. 3H]Threo-(±)-methylphenidate binding to 3,4-dihydroxyphenethylamine uptake sites in corpus striatum. Correlation with the stimulant properties of ritalinic esters J. Neurochem. 45:1985;1062-1070.
41. 1 agonist SKF 82958 and SKF 77434 are self-administered by rats. Brain Res. 582:1992;349-352.
42. 10 dopamine autoreceptors in vitro. Brain Res. 558:1991;141-144.
43. Sokoloff P., Giros B., Martes M.-P., Bouthenet M.-L., Schwartz J.-C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347:1990;146-151.
44. Spealman R. D., Goldberg S. R. Drug self-administration by laboratory animals. Control by schedules of reinforcement Annu. Rev. Pharmacol. Toxicol. 18:1978;313-339.
45. Van Tol H. M. M., Bunzow J. R., Guan H.-C., Sunahara R. K., Seeman P., Nizik H. B., Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614.
46. Volkow N. D., Ding Y.-S., Fowler J. S., Wang G. J., Logan J., Gatley J. S., Dewey S., Ashby C., Liebermenn J., Hitzemann R., Wolf A. P. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch. Gen. Psychiatry. 52:1995;456-463.
47. Volkow N. D., Mullani N., Gould K. L., Adler S., Krajewski K. Cerebral blood flow in chronic cocaine users. A study with positron emission tomography Br. J. Psychiatry. 152:1988;641-648.
48. 11C]raclopride in the human brain. Synapse. 16:1994;255-262.
49. Wang G.-J., Volkow N. D., Fowler J. S., Ferrieri R., Schlyer D. J., Alexoff D., Pappas N., Lieberman J., King P., Warner D., Wong C., Hitzemann R. J., Wolf A. P. Methylphenidate decreases regional cerebral blood flow in normal human subjects. Life Sci. 54:1994;PL143-146.
50. Weed M. R., Vanover K. E., Woolverton W. L. Reinforcing effect of the D1 dopamine agonist SKF 81297 in rhesus monkeys. Psychopharmacology. 113:1993;51-52.
51. Weed M. R., Woolverton W. L. The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 275:1995;1367-1374.
52. White F. J., Wang R. Y. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic d-amphetamine treatment. Brain Res. 309:1984;283-292.
53. Woolverton W. L., Goldberg L. I., Ginos J. Z. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J. Pharmacol. Exp. Ther. 230:1984;678-683.
54. Woolverton W. L., Nader M. A. Experimental evaluation of the reinforcing effects of drugs. Adler M. W., Cowan A. Testing and evaluation of drugs of abuse. 1990;165-192 Wiley-Liss, Inc, New York.